Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
2
×
deals
fda
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
abbvie
achromatopsia
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
beta-thalassemia
bill cassidy
biogen
biotech
bluebird bio
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
dna
durvalumab
editas medicine
europe blog main
What
deal
years
2
×
acquisitions
age
announced
bigger
biggest
bio
ceo
collabs
come
covid
daniel
emerging
gave
gene
gilead
gilead’s
help
introduce
ipo
j
johnson
medicines
meiragtx
month
morning
o’day
past
plans
roundup
sciences
signal
signals
therapy
transformative
Language
unset
Current search:
years
×
fda
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy